Kapi'olani Medical Center for Women and Children is a clinical research site located in Honolulu, Hawaii, United States 96826.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Kapi'olani Medical Center for Women and Children has participated in 17 clinical trials with 6 currently active.
Therapeutic areas: Hyperbilirubinemia, Neonatal, HER2-positive Breast Cancer, Preterm Delivery.
Sponsors: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company, Seagen, a wholly owned subsidiary of Pfizer, Juniper Pharmaceuticals, Inc..
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Kapi'olani Medical Center for Women and Children has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kapi'olani Medical Center for Women and Children has 17 clinical trials on record, with 6 currently active. Their work covers Hyperbilirubinemia, Neonatal, HER2-positive Breast Cancer, Preterm Delivery.
Yes — Kapi'olani Medical Center for Women and Children holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.